NANOG and metabolic dysfunction-associated steatotic liver disease: It has also been reported that LCSCs can maintain stemness by enhancing fatty acid oxidation while inhibiting mitochondrial oxidative phosphorylation activity in the condition of NANOG-mediated stemness maintenance and nonalcoholic fatty liver disease (NAFLD)-HCC initiation [42, 43].